Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

192 trials

NCT06934252
Recruiting
Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Phase 1 · Australia, New Zealand · 19 sites
Registry update: 28 Oct 2026
NCT07022288
Recruiting
A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic Dermatitis
Not applicable · China · 1 site
Registry update: 15 Jun 2025
NCT06943469
Recruiting
Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
Not applicable · Belgium, Germany, Spain, France, Poland · 25 sites
Registry update: 30 Jul 2026
NCT06946641
Recruiting
A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
Phase 1 · China · 1 site
Registry update: 31 Jul 2025
NCT07204561
Recruiting
CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis
Not applicable · Italy · 1 site
Registry update: 2 Oct 2025
NCT06855745
Recruiting
Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Phase 2 · Australia · 12 sites
Registry update: 1 Aug 2025
NCT06636240
Recruiting
Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis
Not applicable · Taiwan · 1 site
Registry update: 25 May 2025
NCT06856954
Recruiting
The Skin Barrier in Users of Diabetes Devices
Not applicable · Sweden · 1 site
Registry update: 9 Sept 2025
NCT06850311
Recruiting
Herbal Ointment in Treating Atopic Dermatitis Topically
Phase 2/3 · Taiwan · 1 site
Registry update: 27 Feb 2025
NCT06808477
Recruiting
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Phase 1 · Australia, New Zealand, Poland, United States · 14 sites
Registry update: 29 Sept 2026
NCT07558668
Recruiting
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Phase 1 · Bulgaria, Germany, Denmark, United Kingdom, Ireland, United States · 14 sites
Registry update: 30 Apr 2026
NCT06801821
Recruiting
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Not applicable · Italy · 1 site
Registry update: 26 Aug 2025
NCT06732414
Recruiting
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Not applicable · United States · 1 site
Registry update: 15 Oct 2026
NCT06815380
Recruiting
A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
Not applicable · Denmark · 1 site
Registry update: 7 Feb 2025
NCT06884163
Recruiting
Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics
Not applicable · Italy · 1 site
Registry update: 19 Mar 2025
NCT06529913
Recruiting
Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases
Not applicable · Italy · 2 sites
Registry update: 24 Feb 2026
NCT06503510
Recruiting
Role of Interleukin-13 Pathways on Pain and Itch Sensitivity
Not applicable · Denmark · 3 sites
Registry update: 9 Nov 2026
NCT07659756
Recruiting
Global Healthcare Study on Atopic Dermatitis
Not applicable · Switzerland · 1 site
Registry update: 22 Jun 2026
NCT06723080
Recruiting
Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
Phase 3 · China · 1 site
Registry update: 27 Jul 2026
NCT06570889
Recruiting
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Phase 3 · Denmark · 1 site
Registry update: 30 Sept 2025

Ordered by registry start date. Freshness and sponsorship never change the order.